UCSF home page UCSF home page About UCSF Search UCSF UCSF Medical Center
UCSF navigation bar
banner
HRPP LOGO
For New Investigators For Researchers
and Staff
Committee on Human Research About the Committee
phone

Contact Information

Organization

Applying to the CHR Applying & Reporting to the CHR
forms and templates Applications & Forms
Recruitment and Consent Process Recruitment & Consent Process
policies and guidelines UCSF Guidance on Research Topics & Issues
Veterans Affairs Medical Center Logo Working With the VA
Working with Other Institutions and Units Working With Other Institutions & Units
For Research Volunteers For Research Volunteers
quality improvement unit About the Quality Improvement Unit (QIU)
Education & Training
Status Checks and Research Online Status Checks & Research Online
HIPAA and Research HIPAA & Research
Federal Regulations and Guidance Federal Regulation & Guidance
key Other Useful Links
CHR Member Information CHR Member Information
whats new? What's New

THE HUMAN RESEARCH PROTECTION PROGRAM

THE COMMITTEE ON HUMAN RESEARCH

USCF ADVERTISEMENTS, NOTICES, AND/OR MEDIA FORMAT GUIDELINES
(March 2008)

• Requirments
• LImitations


Requirements

The text of any advertisements, notices, and/or media materials must include a reference to UCSF* and should be limited to the following information:

  • The name and address of the investigator or research facility.
  • The condition under study.
  • the purpose of the research.
  • Summary of the criteria used to determine eligibility.
  • Brief list of participation benefits, if any (e.g., a no-cost health examination).
  • Time or other commitment required.
  • Location of the research.
  • Person or office to contact for further information.

An exception may be made for national recruitment campaigns but these will be reviewed on a case-by-case basis.

Limitations

The researcher and the CHR must ensure that the advertisements, notices, and/or media do not:

  • State or imply or imply a certainty of favorable outcome or other benefits beyond what was outlined in the consent document and the protocol.
  • Make claims, either explicitly or implicitly, that the research procedures were safe or effective for the purposes under investigation.
  • Make claims, either explicitly or implicitly, that the research procedures were known to be equivalent or superior to other drugs, biologics, or devices.
  • Use terms such as “new treatment,” “new medication,” or “new drug” without explaining that the test article was investigational.
  • Promise “free treatment” when the intent was only to say participants would not be charged for taking part in the investigation.
  • Emphasize the payment or the amount to be paid, by such means as larger or bold type.
  • Include any language that announces the investigator cannot be held liable or at fault for any research related event.
  • Allow for compensation towards the investigational agent once FDA approved.

Top of page